课题基金 / 基金详情

N-acetylcysteine as a novel prophylactic treatment against nephrotoxicity caused by ifosfamide.

N-acetylcysteine as a novel prophylactic treatment against nephrotoxicity caused by ifosfamide.
N-乙酰半胱氨酸作为一种针对异环磷酰胺引起的肾毒性的新型预防性治疗方法。
批准号:
218931
负责人:
Hanly Lauren N
金额:
$4.08万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-10-01 至 2013-02-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ifosfamide is a chemotherapy drug commonly used to treat solid tumours in children. While it is an effective antineoplastic agent, it has a number of well known side effects including kidney toxicity. Up to 30% of children who are treated with ifosfamide
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金